What are the challenges in conducting large-scale epidemiological studies to assess the risk of rare adverse events following vaccination or exposure to environmental factors?

The purpose of this clinical trial is to compare the effects, good or bad, of satralizumab against placebo in people with NMDAR AIE or LGI1 AIE. People who take ... Jan 23, 2013 ... Learn about interdisciplinary efforts at Duke to treat autoimmune brain disorders from a pediatric neurologist, a pediatric rheumatologist and a medical ... What is Autoimmune encephalitis ... This information is provided by the National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD). To facilitate prompt immunotherapy, new diagnostic criteria for autoimmune encephalitis highlight the importance of clinical recognition.3 Movement ... In fact, based on a recent Mayo Clinic study, autoimmune encephalitis was found to be as common as infectious encephalitis.1 Our full suite of encephalopathy ... Sleep disorders are frequent, often severe, and usually persist beyond the acute disease stage, interfering with patients' recovery and quality of life. Oct 25, 2018 ... Autoimmune Encephalitis. HSS is the #1 orthopedic hospital in the world and a national leader in rheumatology. This content was created by our ... ... autoimmune encephalitis. First, the clinical presentations of the major subtypes are described. Next, an update on the field of N-methyl-d-aspartate ... Mar 20, 2024 ... In this article, we illustrate the main radiological characteristics of autoimmune encephalitis and its subtypes, including the typical limbic presentation. Autoimmune encephalitis defines brain inflammation caused by a misdirected immune response against self-antigens expressed in the central nervous system. It ...